San Diego, CA, United States of America

James R Petisce

This inventor holds 83 USPTO granted patents and 40 published patent applications, plus 7 CIPO patents and 21 EPO patents, primarily in Analyte Sensors (CPC class A61B5-14532). Top assignees: Dexcom, Inc., Becton Dickinson and Company Limited, Edwards Lifesciences Corporation. Active years: 2006-2026.

USPTO Granted Patents = 83 

% Patents Active = 96.4


 

Average Co-Inventor Count = 4.4

ph-index = 36

Forward Citations = 11,838(Granted Patents)

Forward Citations (Not Self Cited) = 10,620(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • San Clemente, CA (US) (2011 - 2017)
  • San Diego, CA (US) (2006 - 2021)
  • Westford, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 2006-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Analyte Sensor
Blood Culture Measurement
Diabetes Management
Continuous Analyte Sensor
Polymeric Dyes
Glucose Detection
Medical Device Calibration
Oxygen Enhancing Membrane
Transcutaneous Sensors
Signal Normalization
Telemetry Link
Insulin Leakage
83 patents (USPTO):Explore Patents

Title: **James R. Petisce: A Leading Innovator in Blood Culture Measurement Systems**

Introduction

James R. Petisce, based in San Diego, CA, is a renowned inventor with a prolific portfolio of 82 patents. His work has significantly advanced the field of biomedical engineering, particularly in the areas of blood culture measurement and detection technologies.

Latest Patents

Among his most recent innovations are two noteworthy patents:

1. **Systems and methods for normalizing signals in blood culture measurement systems** - This invention describes advanced systems for optimizing the detection of optical signals that indicate the presence of specific analytes in blood samples. The process involves inoculating a blood culture test vial with a sample, transmitting light at an excitation frequency to the vial, and measuring the intensity of emitted fluorescence signals. The measured fluorescence signals are then normalized using a reference signal that is independent of the intensity from the test vial. Additionally, this system includes a measurement technique that uses fluorescence signals from reference vials under extreme pH conditions to enhance accuracy and address variability in measurement system hardware.

2. **Polymeric dyes and uses thereof** - This patent discloses innovative polymeric dyes and their preparation. These dyes are particularly valuable for detecting biological activity in samples, including the identification of bacteria in blood.

Career Highlights

James has worked with reputable companies such as Dexcom, Inc. and Becton Dickinson and Company Limited. His expertise and innovative approach have contributed significantly to the development of next-generation biomedical applications.

Collaborations

Throughout his career, James has collaborated with distinguished professionals in his field, including coworkers like Peter C. Simpson and Mark C. Brister. These collaborations have fostered a creative environment that encourages the advancement of innovative technologies.

Conclusion

James R. Petisce stands out as a leader in the biomedical engineering domain, with his extensive patent portfolio reflecting his commitment to innovation. His inventions continue to improve medical diagnostics and enhance patient care, while his collaborative spirit drives further advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…